Diletta Bianchini
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations
Schmid S, De Giorgi U, Hansen A, Beer T, Lavaud P, Morales-Barrera R, Tucci M, Castro E, Karalis K, Bergman A, Le M, Zürrer-Härdi U, Pezaro C, Suzuki H, Zivi A, Klingbiel D, Schär S, Bianchini D, Chi K, Omlin A, Higano C, Sweeney C, Martinez Chanza N, Mehra N, Kuppen M, Beltran H, Conteduca V, Vargas Pivato de Almeida D, Cotait Maluf F, Oh W, Tsao C, Sartor O, Ledet E, Di Lorenzo G, Yip S, Gillessen S. Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations. JAMA Netw Open 2020; 3:e2021692.
Oct 1, 2020Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations
Oct 1, 2020JAMA Netw Open 2020; 3:e2021692
Schmid Sabine, De Giorgi Ugo, Hansen Aaron R, Beer Tomasz M, Lavaud Pernelle, Morales-Barrera Rafael, Tucci Marcello, Castro Elena, Karalis Kostas, Bergman Andries M, Le Mo Linh, Zürrer-Härdi Ursina, Pezaro Carmel, Suzuki Hiroyoshi, Zivi Andrea, Klingbiel Dirk, Schär Sämi, Bianchini Diletta, Chi Kim N, Omlin Aurelius, Higano Celestia, Sweeney Christopher, Martinez Chanza Nieves, Mehra Niven, Kuppen Malou C P, Beltran Himisha, Conteduca Vincenza, Vargas Pivato de Almeida Daniel, Cotait Maluf Fernando, Oh William K, Tsao Che-Kai, Sartor Oliver, Ledet Elisa, Di Lorenzo Giuseppe, Yip Steven M, Gillessen Silke
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Rescigno P, Romero-Laorden N, Castro E, Saez M, Mehra N, Smeenk S, Sideris S, Gil T, Banks P, Sandhu S, Sternberg C, De Giorgi U, Olmos D, Morley C, Pezaro C, Dolling D, Conteduca V, Rediti M, Bianchini D, Lolli C, Ong M, Li H, Omlin A, Schmid S, Caffo O, Zivi A, de Bono J. Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis. Eur Urol Oncol 2019
Jul 12, 2019Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Jul 12, 2019Eur Urol Oncol 2019
Rescigno Pasquale, Romero-Laorden Nuria, Castro Elena, Saez Maria I, Mehra Niven, Smeenk Stella, Sideris Spyridon, Gil Thyerry, Banks Patricia, Sandhu Shaneen K, Sternberg Cora N, De Giorgi Ugo, Olmos David, Morley Courtney, Pezaro Carmel J, Dolling David, Conteduca Vincenza, Rediti Mattia, Bianchini Diletta, Lolli Cristian, Ong Michael, Li Haoran, Omlin Aurelius, Schmid Sabine, Caffo Orazio, Zivi Andrea, de Bono Johann S
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey
Lorente D, Hall E, IJzerman M, Terstappen L, Payne H, Mateo J, Perez R, Tunariu N, Bianchini D, Porta N, Kolinsky M, Rescigno P, Miranda M, Gilman A, Omlin A, Pezaro C, Mehra N, Ravi P, de Bono J. Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey. Eur Urol Focus 2016; 4:235-244.
Oct 10, 2016Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey
Oct 10, 2016Eur Urol Focus 2016; 4:235-244
Lorente David, Hall Emma, IJzerman Maarten, Terstappen Leon, Payne Heather, Mateo Joaquin, Perez Raquel, Tunariu Nina, Bianchini Diletta, Porta Nuria, Kolinsky Michael, Rescigno Pasquale, Miranda Miguel, Gilman Alexa, Omlin Aurelius, Pezaro Carmel, Mehra Niven, Ravi Praful, de Bono Johann
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
Lorente D, Crespo M, Flohr P, Mateo J, Altavilla A, Ferraldeschi R, Bianchini D, Attard G, Tunariu N, Miranda S, Riisnaes R, Omlin A, Zafeiriou Z, Nava-Rodrigues D, Pérez-López R, Pezaro C, Mehra N, Sheridan E, Figueiredo I, de Bono J. Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses. Clin Genitourin Cancer 2016; 14:485-493.
May 5, 2016Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
May 5, 2016Clin Genitourin Cancer 2016; 14:485-493
Lorente David, Crespo Mateus, Flohr Penny, Mateo Joaquin, Altavilla Amelia, Ferraldeschi Roberta, Bianchini Diletta, Attard Gerhardt, Tunariu Nina, Miranda Susana, Riisnaes Ruth, Omlin Aurelius, Zafeiriou Zafeiris, Nava-Rodrigues Daniel, Pérez-López Raquel, Pezaro Carmel, Mehra Niven, Sheridan Elizabeth, Figueiredo Ines, de Bono Johann
Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer
Pérez-López R, Koh D, de Bono J, Leach M, Zivi A, Omlin A, Bianchini D, Mateo J, Collins D, Blackledge M, Lorente D, Tunariu N. Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer. Radiology 2016; 280:151-60.
Jan 25, 2016Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer
Jan 25, 2016Radiology 2016; 280:151-60
Pérez-López Raquel, Koh Dow-Mu, de Bono Johann S, Leach Martin O, Zivi Andrea, Omlin Aurelius, Bianchini Diletta, Mateo Joaquin, Collins David J, Blackledge Matthew D, Lorente David, Tunariu Nina
PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
Ferraldeschi R, Sideris S, Bianchini D, Grist E, Thway K, Perez Lopez R, Tunariu N, Parker C, Dearnaley D, Reid A, Attard G, Altavilla A, Mateo J, Nava Rodrigues D, Riisnaes R, Miranda S, Figueiredo I, Rescigno P, Ravi P, Pezaro C, Omlin A, Lorente D, Zafeiriou Z, de Bono J. PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate. Eur Urol 2014
Nov 4, 2014PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
Nov 4, 2014Eur Urol 2014
Ferraldeschi Roberta, Sideris Spyridon, Bianchini Diletta, Grist Emily, Thway Khin, Perez Lopez Raquel, Tunariu Nina, Parker Chris, Dearnaley David, Reid Alison, Attard Gerhardt, Altavilla Amelia, Mateo Joaquin, Nava Rodrigues Daniel, Riisnaes Ruth, Miranda Susana, Figueiredo Ines, Rescigno Pasquale, Ravi Praful, Pezaro Carmel, Omlin Aurelius, Lorente David, Zafeiriou Zafeiris, de Bono Johann
Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer
Lorente D, Chowdhury S, Attard G, Zivi A, Ferraldeschi R, Pezaro C, Omlin A, Rodriguez-Vida A, Bianchini D, de Bono J. Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer. Eur J Cancer 2014; 50:1042-3.
Jan 13, 2014Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer
Jan 13, 2014Eur J Cancer 2014; 50:1042-3
Lorente David, Chowdhury Simon, Attard Gerhardt, Zivi Andrea, Ferraldeschi Roberta, Pezaro Carmel, Omlin Aurelius, Rodriguez-Vida Alejo, Bianchini Diletta, de Bono Johann S
Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents
Pezaro C, de Bono J, Parker C, Dearnaley D, Bianchini D, Ferraldeschi R, Lorente D, Altavilla A, Omlin A, Attard G. Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents. Eur Urol 2013
Dec 17, 2013Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents
Dec 17, 2013Eur Urol 2013
Pezaro Carmel J, de Bono Johann S, Parker Christopher, Dearnaley David, Bianchini Diletta, Ferraldeschi Roberta, Lorente David, Altavilla Amelia, Omlin Aurelius, Attard Gerhardt
Visceral Disease in Castration-resistant Prostate Cancer
Pezaro C, de Bono J, Tunariu N, Crespo M, Altavilla A, Riisnaes R, Mukherji D, Bianchini D, Ferraldeschi R, Nava Rodrigues D, Lorente D, Omlin A, Attard G. Visceral Disease in Castration-resistant Prostate Cancer. Eur Urol 2013; 65:270-3.
Nov 22, 2013Visceral Disease in Castration-resistant Prostate Cancer
Nov 22, 2013Eur Urol 2013; 65:270-3
Pezaro Carmel J, de Bono Johann S, Tunariu Nina, Crespo Mateus, Altavilla Amelia, Riisnaes Ruth, Mukherji Deborah, Bianchini Diletta, Ferraldeschi Roberta, Nava Rodrigues Daniel, Lorente David, Omlin Aurelius, Attard Gerhardt
Improved survival in a cohort of trial participants with metastatic castration-resistant prostate cancer demonstrates the need for updated prognostic nomograms
Omlin A, Attard G, Parker C, Thompson E, Maier G, Ferraldeschi R, Olmos D, Bianchini D, Sandhu S, Mulick Cassidy A, Mukherji D, Pezaro C, de Bono J. Improved survival in a cohort of trial participants with metastatic castration-resistant prostate cancer demonstrates the need for updated prognostic nomograms. Eur Urol 2013; 64:300-6.
Jan 4, 2013Improved survival in a cohort of trial participants with metastatic castration-resistant prostate cancer demonstrates the need for updated prognostic nomograms
Jan 4, 2013Eur Urol 2013; 64:300-6
Omlin Aurelius, Attard Gerhardt, Parker Chris, Thompson Emilda, Maier Gal, Ferraldeschi Roberta, Olmos David, Bianchini Diletta, Sandhu Shahneen, Mulick Cassidy Amy, Mukherji Deborah, Pezaro Carmel, de Bono Johann